Terry Opgenorth
Chairman at KromaTid, Inc.
Profile
Terry J.
Opgenorth is the founder of VetDC, Inc. founded in 2009.
He currently holds the position of Chairman at KromaTid, Inc. since 2010, Chairman at PhotonPharma, Inc., Executive Director at NeoTREX, Inc., Director at Colorado Institute, Director at Colorado Institute For Drug Device & Diagnostic Development, and Independent Director at Sparta Healthcare Acquisition Corp.
Dr. Opgenorth's former positions include Chief Executive Officer & Director at Vidasym, Inc., Director at Cetya Therapeutics, Inc., Partner at Elanco Animal Health, Inc., and Divisional Vice President at Abbott Laboratories from 1987 to 2007.
He also served as Director at Keystone Symposia and Executive Director at Colorado State University Ventures, Inc. Dr. Opgenorth's education includes an undergraduate degree from Calvin University and undergraduate and doctorate degrees from the University of Illinois.
Terry Opgenorth active positions
| Companies | Position | Start |
|---|---|---|
NeoTREX, Inc.
 NeoTREX, Inc. Medical/Nursing ServicesHealth Services NeoTREX, Inc. provides healthcare services. The non-profit company is based in Fort Collins, CO. | Director/Board Member | - |
| Colorado Institute | Director/Board Member | - |
Colorado Institute For Drug Device & Diagnostic Development
 Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services The Colorado Institute For Drug Device & Diagnostic Development provides health maintenance services. The American company was founded by Richard C. Duke. | Director/Board Member | - |
KromaTid, Inc.
 KromaTid, Inc. Pharmaceuticals: MajorHealth Technology KromaTid, Inc. provides products and services for mutation detection and disease diagnosis. Its services include high resolution screening of individual genes to the entire genome, sequence, location and orientation from a single assay, cost effective discovery of inversions and translocations, rapid assay development and data delivery. The company was founded by Andrew F. Ray, Susan M. Bailey, Michael Cornforth, Edwin Goodwin, and Joel S. Bedford in 2007 and is headquartered in Longmont, CO. | Chairman | 2009-12-31 |
Sparta Healthcare Acquisition Corp.
 Sparta Healthcare Acquisition Corp. Financial ConglomeratesFinance Sparta Healthcare Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 12, 2021 and is headquartered in Fort Collins, CO. | Director/Board Member | - |
PhotonPharma, Inc.
 PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is a company that is developing a personalized therapeutic cancer vaccine called Innocell. The company is based in Fort Collins, CO, at the Research Innovation Center of Colorado State University. The vaccine is designed using autologous tumor tissue and a photochemical inactivation platform that uses riboflavin and UV light to render tumor cells incapable of replication while still being able to metabolize, express proteins, present antigen, and stimulate immune recognition and response mechanisms. The company has demonstrated the ability of this technology to prevent metastatic tumor formation, reduce the growth of tumors, and stimulate cellular immune response pathways in preclinical development animal models. The company was founded in 2018 by Raymond Goodrich, and the CEO is Alan S. Rudolph. | Chairman | - |
Former positions of Terry Opgenorth
| Companies | Position | End |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 2006-12-31 |
| ELANCO ANIMAL HEALTH INCORPORATED | Corporate Officer/Principal | - |
Cetya Therapeutics, Inc.
 Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | Director/Board Member | - |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Terry Opgenorth
| Calvin University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| Private companies | 11 |
|---|---|
VetDC, Inc.
 VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Process Industries |
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology KromaTid, Inc. provides products and services for mutation detection and disease diagnosis. Its services include high resolution screening of individual genes to the entire genome, sequence, location and orientation from a single assay, cost effective discovery of inversions and translocations, rapid assay development and data delivery. The company was founded by Andrew F. Ray, Susan M. Bailey, Michael Cornforth, Edwin Goodwin, and Joel S. Bedford in 2007 and is headquartered in Longmont, CO. | Health Technology |
Keystone Symposia
 Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Commercial Services |
Colorado State University Ventures, Inc.
 Colorado State University Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services Colorado State University Ventures, Inc. provides intellectual property, licensing, partnership-building and entrepreneurship services. It offers business technology transfer and commercialization services. The firm provides its services to the corporate, private and government sectors. The company was founded in 2007 and is headquartered in Fort Collins, CO. | Commercial Services |
NeoTREX, Inc.
NeoTREX, Inc. Medical/Nursing ServicesHealth Services NeoTREX, Inc. provides healthcare services. The non-profit company is based in Fort Collins, CO. | Health Services |
| Colorado Institute | |
Colorado Institute For Drug Device & Diagnostic Development
Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services The Colorado Institute For Drug Device & Diagnostic Development provides health maintenance services. The American company was founded by Richard C. Duke. | Health Services |
Vidasym, Inc.
 Vidasym, Inc. Pharmaceuticals: GenericHealth Technology Vidasym, Inc. develops drugs for the treatment of kidney diseases and osteoporosis. The private company is based in Chicago, IL. | Health Technology |
Cetya Therapeutics, Inc.
Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | Health Technology |
Sparta Healthcare Acquisition Corp.
Sparta Healthcare Acquisition Corp. Financial ConglomeratesFinance Sparta Healthcare Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 12, 2021 and is headquartered in Fort Collins, CO. | Finance |
PhotonPharma, Inc.
PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is a company that is developing a personalized therapeutic cancer vaccine called Innocell. The company is based in Fort Collins, CO, at the Research Innovation Center of Colorado State University. The vaccine is designed using autologous tumor tissue and a photochemical inactivation platform that uses riboflavin and UV light to render tumor cells incapable of replication while still being able to metabolize, express proteins, present antigen, and stimulate immune recognition and response mechanisms. The company has demonstrated the ability of this technology to prevent metastatic tumor formation, reduce the growth of tumors, and stimulate cellular immune response pathways in preclinical development animal models. The company was founded in 2018 by Raymond Goodrich, and the CEO is Alan S. Rudolph. | Health Technology |
- Stock Market
- Insiders
- Terry Opgenorth
